美国人乳头瘤病毒与乙型肝炎疫苗接种项目实施情况比较:对未来疫苗的启示
本文比较美国人乳头瘤病毒(HPV)疫苗与乙型肝炎病毒(HBV)疫苗接种项目实施情况,二者均推荐所有儿童接种且均经性接触传播、需多剂次完成。作者识别出影响二者接种路径差异的四大因素:接种后勤挑战、父母与医护人员态度、安全性担忧和成本,并针对每个因素提出建议以应对未来疫苗可能出现的类似障碍。
要点
- HPV疫苗与HBV疫苗均推荐所有儿童接种,均经性接触传播且需多剂次完成。
- 目前多数州仅HBV疫苗入学强制接种有支持,HPV疫苗接种率远落后于美国公共卫生目标。
- 作者识别出影响二者差异的四大因素:接种后勤挑战、父母与医护人员态度、安全性担忧和成本。
核心结论
- 作者认为性别中立的州强制接种结合学校接种项目、制药公司与医护人员更强的性别中立信息传递以及若获批的更年轻接种年龄,是提高HPV疫苗及未来类似疫苗接种率最有前景的方法。
研究设计与样本
- 本文为综述,旨在审视可能导致HPV疫苗与HBV疫苗不同接种路径的因素。
主要发现
- HBV疫苗接种项目的最终成功曾导致预测HPV疫苗也可达到类似高接种率,但HPV疫苗接种率远落后于美国公共卫生目标。
- 多数州仅有HBV疫苗入学强制接种支持,而无HPV疫苗相应强制接种。
- 作者识别出四大因素:接种后勤挑战、父母与医护人员态度、安全性担忧和成本。
临床怎么用
- 作者建议针对每个识别出的因素提出建议,以应对未来疫苗可能出现的类似障碍。
- 作者认为性别中立的州强制接种结合学校接种项目、更强的性别中立信息传递以及更年轻的接种年龄(若获批)是提高HPV疫苗接种率最有前景的方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccines for two viruses which cause cancer, human papillomavirus (HPV) and hepatitis B virus (HBV), are recommended for all children in the United States. Numerous parallels exist between the two vaccines in addition to their roles in cancer prevention, including transmission through sexual contact, multiple doses needed for series completion, and vaccine administration in adolescence for HPV and in the initial phase of the HBV vaccination program. All of these factors were viewed as potential barriers to achieving high rates of coverage, yet the ultimate success of the HBV vaccination program led to predictions that similarly high rates of coverage could be achieved for the HPV vaccine. However, currently, only the recommendation for HBV vaccination is supported by mandates for school entry in most states. Uptake of the HPV vaccine has lagged far behind U.S. goals for public health promotion. The aim of this paper is to examine factors which may account for the divergent pathways of the two vaccines. Four main factors are identified: logistical challenges of vaccine administration, attitudes of parents and healthcare providers, safety concerns, and cost. For each factor examined, recommendations are offered to confront similar barriers likely to arise for future vaccines. The authors conclude that gender-neutral state mandates coupled with school-located vaccination programs, stronger gender-neutral messaging from pharmaceutical companies and healthcare providers, and younger age of vaccine administration, if approved, present the most promising approaches to improving uptake of the HPV vaccine, and similar vaccines down the road.
引用
- Constable C, Caplan A. Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines. Vaccine. 2019. PMID: 31843271. doi:10.1016/j.vaccine.2019.11.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。